Thiethylperazine
Thiethylperazine (Torecan) is an antiemetic of the phenothiazine class. Though it was never licensed or used as an antipsychotic, it may have such effects.
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code |
|
| Pharmacokinetic data | |
| Protein binding | 60% |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.014.381  |
| Chemical and physical data | |
| Formula | C22H29N3S2 |
| Molar mass | 399.62 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Thiethylperazine activates the transport protein ABCC1 that clears beta-amyloid from brains of mice.[1]
References
- Science Daily (September 1, 2011). "Alzheimer Disease: Transport Protein ABCC1 Plays Key Role in Clearing Beta-Amyloid from Brains of Mice". Retrieved September 1, 2011.
Antiemetics (A04) | |
|---|---|
| 5-HT3 serotonin ion channel antagonists |
|
| 5-HT serotonin G-protein receptor antagonists | |
| CB1 agonists (cannabinoids) |
|
| D2/D3 antagonists |
|
| H1 antagonists (antihistamines) | |
| mACh antagonists (anticholinergics) |
|
| NK1 antagonists |
|
| Others |
|
Antihistamines (R06) | |
|---|---|
| Benzimidazoles (*) |
|
| Diarylmethanes |
|
| Ethylenediamines |
|
| Tricyclics |
|
| Others |
|
| For topical use |
|
Dopamine receptor modulators | |||||
|---|---|---|---|---|---|
| D1-like |
| ||||
| D2-like |
| ||||
| |||||
Tricyclics | |
|---|---|
| Classes |
|
| Antidepressants (TCAs and TeCAs) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants |
|
| Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.